Medx Health Corp V.MDX

Alternate Symbol(s): MDXHF

Healthcare Medical Devices

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.

TSXV:MDX - Post by User

Medx Health Corp

Bullboard Posts

Post by Insightful1on Jan 21, 2020 4:12pm

137 Views

Post# 30579709

When will the Brazil PO revenue hit??

As I understand it MedX gets paid 100% upfront for the SIAscopes, so with a PO in hand for 500 scopes we should see this revenue booked upon delivery to Brazil in other words by Q1 it should show on the financials. The recurring revenue model will start to show up in Q2 slightly but by Q4 we should see a srong revenue contribution from the scan revenue. I think MedX needs to get this story out in the USA along with a USA announcement then I think we will see the value bthat MedX has recognized and the share price act accordingly.

Latest shareholder news update; https://investorintel.com/sectors/biotech-healthcare/biotech-intel/medx-health-corp-is-this-just-the-beginning-of-a-global-rollout/

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December